Stock comparison
DEXCOM INC is 17.9x more valuable than NovoCure Ltd by market capitalization ($32.33 B vs $1.81 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
DXCM is larger
DEXCOM INC is 17.9x more valuable than NovoCure Ltd by market capitalization ($32.33 B vs $1.81 B).
Market value leader
DXCM
DEXCOM INC is 17.9x more valuable than NovoCure Ltd by market capitalization ($32.33 B vs $1.81 B).
Revenue leader
DXCM
NVCR: $655.35M vs DXCM: $4.66B.
Profit leader
DXCM
NVCR: -$136.23M vs DXCM: $836.30M.
Margin leader
DXCM
NVCR: -20.8% vs DXCM: 17.9% net margin.
| Metric | NVCR | DXCM |
|---|---|---|
| Market cap | $1.81 B | $32.33 B |
| US-listed rank | #2207 | #445 |
| Revenue (latest FY) | $655.35M | $4.66B |
| Net income (latest FY) | -$136.23M | $836.30M |
| Net margin | -20.8% | 17.9% |
| P/E (trailing FY) | - | 38.7x |
| SEC filings | 1,138 | 2,566 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
DEXCOM INC is 17.9x more valuable than NovoCure Ltd by market capitalization ($32.33 B vs $1.81 B).
In their latest fiscal years, NovoCure Ltd reported $655.35M in revenue while DEXCOM INC reported $4.66B.
Full pages: NovoCure Ltd and DEXCOM INC, or browse the full rankings.